MedAvail Holdings, Inc.
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- MedAvail Holdings, Inc. (MDVLQ) develops and commercializes technology-enabled pharmacy solutions, including self-service kiosks, mobile applications, and robotic dispensing systems for prescription medications in the United States and Canada. The company operates through two primary segments: Retail Pharmacy Services, which historically included SpotRx full-service retail pharmacies primarily serving Medicare patients; and Pharmacy Technology, featuring the proprietary MedAvail MedCenter (including the M4 model), a pharmacist-supervised, patient-interactive kiosk that holds over 600 medications, enables on-site dispensing in medical clinics, retail locations, employer sites, and other venues via audio-visual pharmacist connections, software integration, maintenance services, and customizable formularies. Founded in 2012 through its core entity MedAvail Technologies Inc. and headquartered in Phoenix, Arizona, with additional operations from Mississauga, Ontario, the company targets healthcare providers, health systems, retailers, clinics, and Medicare-focused customers. In recent major developments, MedAvail sold assets of its SpotRx pharmacies in multiple U.S. locations—including Arizona, California, Michigan, and Florida—to CVS Pharmacy in early 2023, using proceeds to reduce debt to approximately $2.5 million and extend its cash runway while shifting focus to pharmacy technology expansion. The company announced partnerships in 2023 for MedCenter deployments, such as agreements with ASP Cares for ten M4 units, Oak Lawn Pharmacy for ten M4 MedCenters, and St. Thomas Community Health Centers for two M4 MedCenters, emphasizing growth in telehealth-enabled dispensing. On February 2, 2024, MedAvail Holdings, Inc., along with affiliates, filed a voluntary petition for Chapter 7 liquidation in the U.S. Bankruptcy Court for the District of Delaware, marking a significant operational wind-down.
MedAvail Announces Agreement with New Orleans-Based St. Thomas Community Health Centers for Deployment of Two M4 MedCenters
MedAvail Receives Nasdaq Notification of Non-Compliance Related to Delayed Quarterly Report on Form 10-Q
MedAvail Announces Agreement with ASP Cares for Deployment of Ten M4 MedCenters
MedAvail Reports Second Quarter 2023 Financial Results
MedAvail Announces Agreement with Dallas-Based Oak Lawn Pharmacy for Deployment of Ten M4 MedCenters
MedAvail Announces 1-for-50 Reverse Stock Split
MedAvail Holdings, Inc. (MDVL) Q1 2023 Earnings Call Transcript
MedAvail to Report First Quarter 2023 Financial Results on May 18
MedAvail to Report First Quarter 2023 Financial Results on May 15
MedAvail Holdings, Inc. (MDVL) Q4 2022 Earnings Call Transcript
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on March 30
Most Oversold Stocks In Consumer Staples Sector: Herbalife, United Natural Foods And More - Herbalife Nutrition (NYSE:HLF), AppHarvest (NASDAQ:APPH)
MedAvail Holdings, Inc. (MDVL) Q3 2022 Earnings Call Transcript
MedAvail To Report 2022 Third Quarter Financial Results on November 10, 2022
MedAvail to Present at the H.C. Wainwright 24th Annual Global Investment Conference
MedAvail to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
MedAvail Holdings, Inc.'s (MDVL) CEO Mark Doerr on Q2 2022 Results - Earnings Call Transcript
5 Penny Stocks To Watch With High Short Interest, Are They A Buy Now?
MedAvail to Participate in Upcoming Investor Conferences